Fernando, W., Clucas, J., Rizzo, A., Singer, R., Goode, E., Tiu, C., Layzell, S., Konecnik, J., Wilson, R., John, S. W., Jouny, S., Guppy, N., Boulat, V., Mannion, J., Goicoechea, M., Tan, S., Lawson, S., Starling, C., Elshtein, G., Ravindran, N., Montgomery, A. B., Andres-Ejarque, R., Allen, M., Lumbard, S., Wallberg, F., Betteridge, K., Scrimgeour, R., Robertson, D., Ward, G., Sims, M., Smyth, T., Samson, A. L., Murphy, J. M., Ivankovic, D. K., Arwert, E. N., Calado, D. P., Grigoriadis, A., Smalley, M. J., Melcher, A., Haider, S., Lawrence, T., Roxanis, I., Tutt, A. N. J., Tenev, T., Meier, P. (2026). Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy. Nature Communications. https://doi.org/10.1038/s41467-026-70133-8